Harsco Global

New Vaccine Offers Full Protection Against Nigeria’s Lassa Fever Strain

A promising breakthrough in the fight against Lassa fever has emerged, as a vaccine developed by a Nigerian virologist has shown 100% protection in preclinical trials. Dr. Simeon Agwale, Chief Executive Officer of Innovative Biotech, disclosed in Abuja that the vaccine—licensed from the University of Melbourne—successfully protected mice and non-human primates against the Nigerian strain […]